Not for distribution to United States Newswire Services or for dissemination in the United States VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) is pleased to announce that it completed on December 18, 2025, the third and final tranche of a non-brokered private placement previously announced on November 14, 2025 (the "Offering"). The third tranche of the Offering consisted of 35,714,285 Non Flow-Through (“NFT ...

Therapists say academic and holiday pressures exacerbate teens’ stress levels, and there are steps parents can take to help.New York, NY , Dec. 18, 2025 (GLOBE NEWSWIRE) -- Talkspace has released a seasonal guide to help families understand why emotional stress tends to peak in December, especially among teens. The resource, informed by licensed mental health professionals, breaks down the unique stressors of the holiday season and academic calendar, and provides families with clear, therapist-backed strate ...

 Future insurance coverage of CBD products has potential to drastically transform the Company’s CBDistillery business Company’s advocacy efforts and legal strategy in DEA proceedings contributed to historic milestone ending prohibition Village remains committed to activating U.S. production assets to meet increasing demand for safe, affordable product LAKE MARY, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF), today commended U.S. P ...

CEO says move enhances company’s broader growth strategyMARYSVILLE, Ohio, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today expressed support for President Trump’s executive order to reschedule cannabis from a Schedule I to Schedule III drug. “With 39 states already legalizing cannabis in some form, rescheduling to a lower level drug on the federal level has been long overdue,” said Chairman ...

COPENHAGEN, Denmark, December 18, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Board of Directors has decided to establish a long-term incentive program for Executive Management as part of the annual remuneration as laid out in the Remuneration Policy, adopted at the annual general meeting. Members of the Executive Management are granted performance restricted stock units (Performance RSUs), subject to the successful achievement of relevant Key Performance Indicators (KPI’s), measured ove ...

Verano’s active operations span 13 states, comprised of 158 dispensaries operating under the Zen Leaf™ and MÜV™ retail banners, and 15 cultivation and processing facilities with more than 1.1 million square feet of cultivation capacity CHICAGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, celebrates today’s historic announcement that President Donald Trump has issued an Executive Order directing the ...

The contemplated financing transactions would provide up to $12 Million in capital to support Celularity’s strategic priorities around longevity and preservation of human performance. FLORHAM PARK, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company addressing age-related and degenerative diseases, today announced that it has entered into two binding term sheets for a senior secured term loan and a secured convertible note finan ...

Global Cannabis Leader Poised for Major U.S. Market Entry, Signaling New Era for HealthcareNEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis healthcare, today confirmed its planned strategic framework to advance its U.S. medical cannabis operations following federal cannabis rescheduling and related regulatory developments. In conjunction with these regulatory changes, Ti ...

NORWOOD, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator committed to improving lives every day, issued the following statement from CEO Jon Levine today. “We commend President Trump and the Trump Administration for reclassifying cannabis as a Schedule III drug. This is the single greatest cannabis reform in US history and will have far-reaching benefits for years to come. Most important, the reclassification means the Fede ...

新闻核心事件 - 美国投资银行Maxim Group于2025年12月18日启动对AB Science股票的研究覆盖 并发布题为“Mastering Mast Cell Inhibition for Neurodegenerative Diseases Starting with ALS”的研究报告 [1][2] - Maxim Group给予AB Science股票“买入”评级 并设定每股4.00欧元的目标价 [1][2] 分析师观点与依据 - 研究报告强调 公司核心药物马赛替尼在三种神经退行性疾病中显示出前景广阔的疗效 这验证了肥大细胞抑制方法的潜力 [3] - 基于马赛替尼的疗效数据和安全性特征 其风险收益特征被视为积极 针对进行性多发性硬化症和轻度阿尔茨海默病的积极数据进一步支持了其神经保护潜力 [3] - 分析师未将阿尔茨海默病或多发性硬化症的潜在收入纳入模型 视其为额外的上行空间 [3] 公司背景与业务 - AB Science成立于2001年 是一家专注于蛋白激酶抑制剂研究、开发和商业化的制药公司 [5] - 公司研发项目专注于存在高度未满足医疗需求的疾病领域 这些疾病通常致命、生存期短、罕见或对现有疗法耐药 [5] - 公司拥有自主知识产权的分子组合 其先导化合物马赛替尼已注册用于兽药 并在人类医学领域针对肿瘤学、神经性疾病、炎症性疾病和病毒性疾病进行开发 [6] - 公司总部位于法国巴黎 在泛欧交易所上市 [6] 市场与覆盖情况 - 此次覆盖完成后 AB Science的股票已获得包括Maxim Group、Chardan、In Extenso Finance和DNA Finance在内的多家金融机构分析师的覆盖 [4]